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The Lancet has rightly given attention to the goals of reducing the burden of maternal and 
childhood undernutrition,
1 focussing primarily on short-term outcomes such as infant survival 
and stunting.
2 However the longer-term effects on adult health of a poor start to life
3 suggest a 
further perspective. Developmental effects have been traditionally viewed in the context of 
teratogens, prematurity and growth retardation. However, developmental plasticity operates 
across  the  entire  environmental  range,  from  undernutrition  to  the  excessive  nutritional 
environments a s s o c i a t e d  w i t h  g e s t a t i o n a l  d i a b e t e s  o r  maternal  obesity,
4,5 l e a d i n g  t o  
multigenerational  cycles  of  disease.
6  The  design  of  intervention  strategies  needs  to  take 
account of these complexities. 
Realising  the  potential  for  health  improvement  across  the  life-course  requires  integrating 
knowledge  from  several  disciplines.  Sponsored  by  the  Rockefeller  Foundation,  an 
interdisciplinary  meeting,  representing c l i n i c i a n s  a n d  p u b l i c  h e a l t h  s p e c i a l i s t s  f r o m  b o t h  
higher and lower income countries, developmental and evolutionary biologists, geneticists, 
anthropologists  and  economists  was  held  in D e c e m b e r  2 0 0 6 .  Our  starting  point  was  the 
question: how might adopting a developmental perspective on the human life-course inform 
efforts to reduce the burden of non-communicable disease, particularly for populations in 
rapid  nutritional  transition?  This  paper s u m m a r i s e s  t h e  c o n c l u s i o n s  f r o m  t h e  e n s u i n g  
dialogue. 
 
Individual variation in risk of chronic disease 
Humans now live in evolutionarily novel environments, and mismatch between our evolved 
physiological  capabilities  and  contemporary  exposures  may  lead  to  ill-health.
7,8 T h i s  i s  
particularly relevant to food preferences and consumption and to energy expenditure, which 
have changed greatly over several decades in affluent societies and more recently in lower 
income countries undergoing socioeconomic improvement. Substantial variations in disease 
risk  exist  between  individuals,  even  in  the  same  environment,
9 a s  w e l l  a s  b e t w e e n  
populations.
10 This may have a genetic component,
11,12 but experimental work in the 1970s, 
followed by retrospective epidemiological cohort studies, has revealed additional non-genetic 
developmental  contributions t o  risk  of  later  disease.  Whilst  caution  must  be  exercised  in 
extrapolating from historical cohorts to current conditions, a wide variety of experimental, 
clinical  and  prospective  epidemiological  studies  show  that  changes  in  maternal  or  infant 
nutrition can produce heritable effects on risk of chronic disease.
13   4 
Timescales of responses to environmental change  
Organisms respond to challenges over a range of timescales (Figure 1). At one extreme, rapid 
and reversible homeostatic mechanisms counter an immediate challenge. Then, stressors or 
exposures during critical developmental periods can affect growth, tissue differentiation and 
physiological  set-points,  influencing  responses  to  environmental  challenges  for  life.  Such 
adaptive  plasticity,  mediated  in  part  by  epigenetic  processes,
14,15  gives  advantage  in 
environments which change over several generations. The fidelity of cues inducing adaptive 
plasticity might be enhanced by integrating the experience of recent generations, and new 
evidence  suggests  that  epigenetic  mechanisms  may  contribute  to  such  non-genomic 
transgenerational  inheritance.
16,17  On  a  longer  timescale,  the  genomes  of  populations  can 
change over many generations as the result of selection or drift, and increasingly there are 
examples of responses to environmental change being integrated into the human genome.
18,19 
Clinical medicine and public health have focused largely on causation and intervention at the 
short-term  end  of  this  spectrum.  It  is  now  important  to  consider  the  consequences  of 
developmental plasticity acting over the intermediate timescale.
20 
 
Developmental processes and longer-term outcomes 
Developmental  plasticity  evolved  because  it  is  adaptive,  promoting D a r w i n i a n  f i t n e s s   by 
enhancing survival and reproductive success.
21 Plasticity uses environmental cues, which in 
mammals are transduced and buffered by the mother, to optimise the life-course strategy for 
maximal fitness, both making the best of present conditions and being well prepared for the 
future environment.
22 The hormones and nutrients crossing the placenta can be affected by the 
mother’s body composition, metabolism and longer-term lifestyle as well as by her immediate 
diet  and  stress  levels.  Thus,  environmental c u e s  a f f e c t ing d e v e l o p m e n t  p r o v i d e  h i s t o r i c a l  
information which offspring use to predict the future.
23 
However, there are limitations to this anticipatory strategy, especially for long-lived species 
such as humans, with the result that challenges during development can induce responses 
which have short-term benefits for the mother or the fetus but then longer-term costs in terms 
of reduced fitness.
24,25 When environmental conditions change markedly between conception 
and  adulthood,  as  has  happened  in  most  present  human  populations,  the  potential  for  a 
substantial  mismatch  is  especially  great  and  this  contributes  to  disease  risk.  Shift  in 
environmental  conditions  between  generations  may  also  exceed t h e  evolved  capacity  for   5 
intergenerational transmission of information. Because in developed societies we now live on 
average twice as long as did our Palaeolithic ancestors, the detrimental effects of inaccurate 
predictions are more likely to be apparent. 
  
Fitness versus health 
Developmental  plasticity  evolved  to  maximize  an  organism’s  Darwinian  fitness,  not 
necessarily its health, and life-course strategies operate to ensure survival to reproduce rather 
than longevity. Anthropological and clinical data support this concept. Women throughout 
hunter-gatherer  societies  show  an  inverse  relationship  between  age  at m e n a r c h e  a n d  
anticipated  life  span,
26  and  in  high-income  countries,  lower  birthweight  individuals h a v e  
earlier menarche, an effect exaggerated by prepubertal weight gain.
27 Although being a small 
(but healthy) individual may not be a ‘disease’ outcome, it incurs costs, in lower reproductive 
fitness, earnings or social status
28, costs which may be – biologically if not ethically – viewed 
as trade-offs for gains in survival through better match of metabolic requirements to energy 
availability. 
Manipulation  of  developmental  cues  might b e  u s e d  t o  s h i f t  t h e  a d a p t i v e  c a p a c i t y  o f  t h e  
organism  to  cope  in  a  later  environment.  This  is  possible  experimentally  (for  example, 
metabolic disease induced by prenatal undernutrition can be prevented by postnatal hormonal 
manipulation
29),  but  it  would  be  premature  to  recommend  prenatal  diets  with  a  view  to 
promoting human offspring health. The impact of multiple micronutrients on fetal growth
30 
and birth outcomes
31 suggests that factors other than energy and protein intake in pregnancy 
may be important. Postnatal plasticity may explain the long-term differences in outcome – 
metabolic and cognitive – for infants fed by breast versus formula.
32,33  
 
Implications for human health and wellbeing 
An  improved  understanding  of  adaptive  developmental  plasticity  has  three  important 
implications for public health. First, interventions to improve adult health may need to start 
early  in  life  and  to  take  a  cross-generational  perspective,  challenging  though  this  is  to 
policymakers  and  funders.  Interventions  starting  in  adult  life  need  to  take  account  of 
developmental history – for example, attempts to change health behaviours in adults may be 
less effective in populations which have, through adaptive responses to past environments of 
food  insecurity,  developed  tendencies  to  excessive  fat  storage. S e c o n d ly,  it  must  be   6 
recognized that interventions in early life aimed at essential short-term gain, such as infant 
survival, may also have longer term effects on individuals throughout their life course, and 
that such effects may not always be beneficial. Programmes aimed at increasing birth weight 
may  increase  the  risk  of  later  diabetes, a m p l i f i e d  by  accelerated  fat  gain  in  childhood, a  
possible consequence of universal supplementation programmes.
34 Thirdly, recent drives to 
develop one uniform standard for human growth
35 assume that optimal health across the life 
course will be achieved through comparable growth in a variety of settings, irrespective of 
factors  such  as  maternal  diet,  body  composition o r  p h y s i c a l  a c t i v i t y .  The  best  outcome 
measure for postnatal growth remains uncertain – Black et al
36 in the recent Lancet series 
proposed stunting (height-for-age) as a better indicator of undernutrition than underweight 
(weight-for-age) but in turn this assumes that the only outcome associated with inappropriate 
undernutrition is that of impaired growth. The design of interventions to promote growth 
demands consideration of the variance of risk of later disease across the whole distribution of 
growth and size, not only that associated with shifting the population mean in what appears to 
be a healthy direction in the short term.
37  
Approaches to interventions for improving maternal and child health have focused largely on 
issues  of  survival, i n  c o n s o n a n c e  w i t h  t h e  M i l l e n n i u m  D e v e l o p m e n t  G o a l s  f o r  r e d u c i n g  
maternal and child mortality substantially by the year 2015.
38 Focusing on early survival, and 
on current differentials due to poverty
39 and social inequalities,
40 may not capture outcomes 
that  have  longer  term  implications  for  adult  health,  life  expectancy, q u a l i t y  o f  l i f e ,  and 
accumulation of human capital. Further, recommendations for nutritional interventions are 
frequently based on improving birth weight, focusing on gains in stature or micronutrient 
status in the short term.
41 Where longer-term follow-up data are available they confirm the 
existence of a window of opportunity for intervention in early childhood, under 24 months of 
age, and only limited benefit, or even harm, of feeding strategies thereafter.
3,42  
Health is often not included in calculations of human capital other than in terms of health 
expenditure, although a healthier population is an economically more productive population. 
Estimates of the true accumulation of human capital embodied in an individual should include 
more than the conventional economic measure of educational attainment: ideally it should 
incorporate  the  impact  of  events  from  conception  or  earlier, p e r h a p s  e v e n  e x t e n d i n g  t o  
measures of intergenerational accrual of biological benefit. 
Robust measures of economic benefit are required to persuade policymakers of the wisdom of 
investing in a life-course approach to health, and we arrived at two specific recommendations.   7 
First,  the  use  of  linear  discount  rates  in  assessing  benefit  disadvantages  early  life 
interventions
43 a n d  h a s  l i m i t a t i o n s  w h e n  c o n s i d e r i n g  i n t e r g e n e r a t i o n a l  e q u i t y .
44  Secondly, 
while  utility-based  measures  of  disease  burden s u c h  a s   DALYs  allow c o m p a r i s o n  o f  
intervention programmes,
2 they fail to capture intergenerational benefit or the monetary value 
of the ensuing savings in healthcare or increases in labour productivity. More sophisticated 
composite measures of outcome are required to demonstrate the true cost-benefit ratio of early 
life interventions. 
The increasing prevalence of metabolic disease worldwide, with its enormous current and 
projected  costs,  challenges  a  wide  range  of  disciplines  to  provide  an  explanation  of  the 
underlying human biology and to define the optimal ways to intervene (Table 1). Merely 
focusing on genetic predisposition or improving adult lifestyle is inadequate. Disease risk 
from  mismatch  is e x a c e r b a t e d  by a  r e l a t i v e l y  s m a l l  c h a n g e  i n  n u t r i t i o n a l  c onditions  in 
societies  starting f r o m  a  l o w  b a s e l i n e  l e v e l ,  and  the  resulting  increased  susceptibility  to 
obesity and gestational diabetes passes risk on to the next generation. Because early growth 
and development is a time in human life when substantial biological stock is transferred to 
future generations,
3,45 i gnori ng t he processes by whi ch t hi s occurs ri sks erosi on of future 
human  capital  in  both  health  and  economic  terms.  As  developmental  plasticity r e s u l t s  in 
variation in human phenotype and life-course strategy, adopting a ‘one size fits all’ approach 
to intervention will fail in efficacy for a percentage of the population, and may put some 
individuals at greater risk of later poor health.   8 
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Figure 1. Modes of human adaptability   10 
Table 1. Adaptive plasticity and human health: research agenda 
 
Basic research 
•  What are the mechanisms by which early life events have long-term effects, and can the 
pathway be altered or reversed?  
•  What is optimal fetal development – how can it be defined in relation to later risk? 
•  What are the indicators of optimal pregnancy outcome – e.g. birth size, duration of pregnancy 
– and what levels of risk do they constitute? 
•  To what extent could markers of specific nutrient status prior to or during pregnancy inform 
about the likely outcomes of the pregnancy? 
•  To what extent could postnatal epigenetic markers inform about the likely life course of the 
offspring? 
•  What are the postnatal windows of plasticity and therefore intervention? 
•  What is the extent and mechanism of intergenerational transmission of disease risk? 
 
Operational research 
•  What is the significance of developmental processes in generating the burden of disease in 
different populations? 
•  What approaches are possible to intervene in individuals and in populations during different 
stages of the life course (preconception, pregnancy, lactation, childhood, adult, parent)? 
•  How  can  developmental  interventions  be  made  context-specific,  balancing  prevention  of 
undernutrition against the later-life consequences of rapid postnatal weight gain? 
•  What level of developmental risk of later chronic disease is acceptable? 
•  How can the various levels of intervention (societal to individual) be designed appropriately 
within the cultural context? 
•  What are the societal costs of less than optimal development, measured with more appropriate 
models than simple discounting? 
•  What  are  the  short-term  and  long-term  economic  benefits  of  optimizing  early-life 
development? 
•  What is the cost-benefit ratio of early intervention? 
•  Which interventions are most likely to be cost effective? 
   11 
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